FREEDOM-1: clinical study for living donor kidney transplant recipients
Study Discontinued
For more information from Talaris Therapeutics, click here
–
–
–
–
Overview
The FREEDOM-1 Study is a clinical research study of an investigational cell therapy, called FCR001. The purpose of this study is to learn more about whether FCR001 can prevent the rejection of living donor kidney transplants without the need for lifelong anti-rejection drugs. FREEDOM-1 is a Phase 3 clinical trial. It will compare the efficacy and safety of FCR001 treatment to standard anti-rejection treatment. This study is now enrolling adults who plan to undergo a living donor kidney transplant.
Study participants and their living donors who enroll in FREEDOM-1 will be randomly assigned as a pair to receive either FCR001 or standard anti-rejection medicines. Your donor and you will be twice as likely to be assigned to the FCR001 group than to the group that receives standard anti-rejection medicines.
You may be eligible for this study if:
-
- You are at least 18 years old
- Your doctor has recommended that you should have a kidney transplant
- This would be your first kidney transplant
- A suitable living kidney donor between ages 18-60 has been identified
- The living kidney donor is willing to undergo standard mobilization and apheresis procedures to donate his/her stem cells
- You have not been diagnosed with or treated for any type of cancer
Locations:
Arizona
Phoenix, AZ
Contact: Leena Abraham @ 480-342-6750 or abraham.leena@mayo.edu
California
Scripps Clinic
La Jolla, CA
Contact: Michelle Meyer @ 858-554-4340
District of Columbia
Georgetown Transplant Institute
Washington, DC
Contact: Alyssa Stucke @ 202.444.1769
Illinois
Chicago, IL
Contact: Dianne Belshe, RN @ (312) 694-0240 dianne.stare@northwestern.edu
Minnesota
University of Minnesota Medical Center
Minneapolis, MN
Contact: Dave Ankarlo @ 612.626.2498
Rochester, MN
Contact: Nong Yowe Braaten @ 507.538.9617 or braaten.nong@mayo.edu
Nebraska
University of Nebraska
Omaha, NE
Contact: Dr. Clifford Miles @ cdmiles@unmc.edu or 402.559.4719
New York
New York-Presbyterian/ Weill Cornell
New York, NY
Contact: Contact: Melissa Eddie @ 212-746-5915
North Carolina
Duke University Medical Center
Durham, NC
Contact: Sherri Swan-Nesbitt @ 919-613-6472
Ohio
The Ohio State University Wexner Medical Center
Columbus, OH
Contact: Corey Newsome @ 614-293-5648 or corey.newsome@osumc.edu
Oregon
Oregon Health and Science University
Portland, OR
Contact: Liz Veasey @ veaseye@ohsu.edu